Non-cancer sample NB2 had a weak expression of CCR5 in more than 33% of the cells, while the other NB1 sample had no expression of CCR5. CCL5 was more abundant, expressed in 50% of brain tissue samples with strong intensity, including NB1 and NB2 samples. This evidence concerns the gene CCL5 and cancer.